title: Sudden enlargement of the prostate in a patient taking Fansidar for malaria.
authors.forename: Blessing C
authors.initials: BC
authors.lastname: Ajuonuma
authors.forename: Mary Uchechi
authors.initials: MU
authors.lastname: Ajuonuma
authors.forename: Adanma
authors.initials: A
authors.lastname: Uzo-Ngerem
authors.forename: Margaret K
authors.initials: MK
authors.lastname: Ajuonuma
authors.forename: Fidelis O
authors.initials: FO
authors.lastname: Ajuonuma
authors.forename: Chika L
authors.initials: CL
authors.lastname: Chukwu
authors.forename: Louis C
authors.initials: LC
authors.lastname: Ajonuma
mesh_terms: D000368:Aged; D000962:Antimalarials / Q000009:adverse effects* / Q000737:chemistry; D004338:Drug Combinations; D006801:Humans; D008288:Malaria / Q000517:prevention & control; D008297:Male; D011470:Prostatic Hyperplasia / Q000139:chemically induced*; D011739:Pyrimethamine / Q000009:adverse effects* / Q000737:chemistry; D013413:Sulfadoxine / Q000009:adverse effects* / Q000737:chemistry
chemical_list: D000962:Antimalarials; D004338:Drug Combinations; C001205:fanasil, pyrimethamine drug combination; D013413:Sulfadoxine; D011739:Pyrimethamine